Hikma Pharmaceuticals (OTCMKTS:HKMPF) Shares Gap Down - Should You Sell?

Key Points

• Hikma Pharmaceuticals shares experienced a significant gap down, opening at $23.98, down from the previous close of $25.21.
• The company's stock has a 50-day moving average of $23.70 and a 200-day moving average of $25.93, indicating a potential downward trend.
• Hikma operates in three segments: Injectables, Generics, and Branded, primarily focusing on generic injectable products for hospitals.

Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF - ) gapped down before the market opened on Wednesday . The stock had previously closed at $25.21, but opened at $23.98. Hikma Pharmaceuticals shares last traded at $23.98, with a volume of 500 shares changing hands.

Hikma Pharmaceuticals Stock Performance

The firm has a 50 day moving average price of $23.70 and a 200 day moving average price of $25.93. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.24 and a quick ratio of 0.72.

About Hikma Pharmaceuticals

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.